We Could Have Had Ozempic Nearly 40 Years Ago
Researchers identified one key breakthrough for GLP-1 drugs in the 1980s, but Pfizer walked away.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.